2024 Emerging Coagulation Tests and Strategic Profiles of Leading Suppliers

This 165-page report presents the clinical significance and market needs for major coagulation laboratory tests, as well as extensive listings of companies developing or marketing new coagulation technologies and products.

The report is available by section, and can be customized to specific information needs and budget.

The report also includes strategic assessments of current and emerging suppliers of coagulation products, including marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

List of tables

Major Companies Developing or Marketing APTT Tests

Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests

Major Companies Developing or Marketing Antithrombin III Tests

Major Companies Developing or Marketing Bleeding Time Tests

Major Companies Developing or Marketing D-dimer Tests

Major Companies Developing or Marketing Factor Assays

Major Companies Developing or Marketing Fibrin Degradation
Product Tests

Major Companies Developing or Marketing Fibrinogen Tests

Major Companies Developing or Marketing Heparin Tests

Major Companies Developing or Marketing Plasmin Tests

Major Companies Developing or Marketing Plasminogen Tests

Major Companies Developing or Marketing Plasminogen
Activator Inhibitor Tests

Major Companies Developing or Marketing Platelet Aggregation Tests

Major Companies Developing or Marketing Protein C Tests

Major Companies Developing or Marketing Protein S Tests



Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests

20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrands Factor
Competitive Assessments
- Abbott
- ADI/American Diagnostica
- Alere/Biosite/Inverness
- Axis-Shield
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio/Data Corporation
- Chrono-Log
- Corgenix Medical
- Diagnostica Stago/Trinity Biotech
- Grifols
- Helena Laboratories
- Hyphen BioMed
- Instrumentation Laboratory
- ITC/Nexus Dx
- Roche
- Siemens
- Sienco
- Sysmex
- Thermo Fisher
- ZyCare/Alere

List Of Tables



Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation
Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen
Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests

Major Companies Developing or Marketing PT Tests

Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrands
Factor Tests

2024 Europe Diagnostics Market Forecasts for 500 Tests: 38-Country Analysis--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM--Competitive Strategies, Opportunities for Suppliers

This new report provides granular analysis of the Europe diagnostic testing market, including: Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary,

USD 35000 View Report

2024 LATAM 22-Country Diagnostics Market for 500 Tests: Blood Banking, Cancer, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM--Competition, Opportunities

This new report provides granular analysis of the Latin America diagnostic testing market, including:Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica,

USD 24500 View Report

Emerging Coagulation Testing Market: Innovative Technologies and Strategic Profiles of Leading Suppliers

This 124-page report provides assessments of such technologies as chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for coagulation testing.The report also includes strategic

USD 1500 View Report

2024 Emerging US Diagnostic Testing Market: Supplier Shares by Test and Segment Sales Forecasts

This new report provides an overview of the US diagnostic testing market.The report is available by section, and can be customized to specific information needs and budget, including sales and

USD 3750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available